Quinoxalin-3-one derivatives as orexin receptor antagonists
US7538109B2 · kind B2 · utility
7Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2004 |
| Grant date | May 26, 2009 |
| Priority date | — |
| Expiry date | Jun 7, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D241/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to quinoxalinone derivatives of general Formula (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists. General Formula (I) wherein X and R1-R9 are as defined in the description
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.